Related Experiment Video
Updated: Jul 8, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.
Dennis Revicki1, Ron D Hays, David Cella
1Center for Health Outcomes Research, United Biosource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. dennis.revicki@unitedbiosource.com
Journal of Clinical Epidemiology
|January 8, 2008
Summary
Determining the minimal important difference (MID) for patient-reported outcome (PRO) measures requires multiple methods. Anchor-based approaches using patient and clinical data are recommended for reliable MID estimates.
Area of Science:
- Health Outcomes Research
- Clinical Trial Methodology
- Psychometrics
Background:
- Patient-reported outcome (PRO) measures are crucial for assessing treatment effects.
- Evaluating the responsiveness and minimal important difference (MID) of PROs is essential for interpreting clinical significance.
- Standardized methods for determining MID are needed to ensure consistent and meaningful interpretation of PRO data.
Purpose of the Study:
- To review and synthesize recommendations for evaluating the responsiveness of PRO measures.
- To summarize methods for estimating the minimal important difference (MID) for PRO instruments.
- To provide guidance on best practices for responsiveness and MID determination.
Main Methods:
- Systematic review and integration of existing literature on PRO responsiveness and MID.
- Analysis of various statistical and clinical approaches for estimating MID.
- Synthesis of recommendations for best-practice methodologies.
Main Results:
- The MID is context-dependent and not a fixed value for a PRO instrument.
- Multiple methods, including triangulation, should be used to estimate MID.
- Anchor-based methods (patient-rated, clinician-rated, disease-specific) are primary for meaningful MID estimates.
- Clinical trial results and distribution-based methods can support MID determination.
Conclusions:
- Minimal important difference (MID) estimation should prioritize patient-based and clinical anchors.
- Clinical trial data should be integrated to refine understanding of MID.
- A multi-method approach ensures robust and contextually relevant MID estimates for PRO measures.
Related Concept Videos
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:28Methods of Medium Optimization
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
01:11Guidelines for Writing Outcome
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
01:16Response Surface Methodology
Response Surface Methodology (RSM) is a collection of statistical and mathematical techniques used to develop, improve, and optimize processes. It is particularly valuable when many input variables or factors potentially influence a response variable.
The process of RSM involves several key steps:
The process of RSM involves several key steps:
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...